about
Wine polyphenols: potential agents in neuroprotectionImmunization with amyloid-beta attenuates inclusion body myositis-like myopathology and motor impairment in a transgenic mouse modelGenetic variants associated with neurodegenerative Alzheimer disease in natural modelsLink between Aluminum and the Pathogenesis of Alzheimer's Disease: The Integration of the Aluminum and Amyloid Cascade HypothesesThe possible place of cathepsins and cystatins in the puzzle of Alzheimer disease: a review.Cascading glia reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling.Effect of surfaces on amyloid fibril formation.CARDIOVASCULAR RISK FACTORS AFFECT HIPPOCAMPAL MICROVASCULATURE IN EARLY AD.Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation.Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease.Polarized sorting of beta-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals.Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases.Natural compounds may open new routes to treatment of amyloid diseasesStudies on free radicals, antioxidants, and co-factorsAntioxidant activity of proteins and peptides.Differential transgene expression patterns in Alzheimer mouse models revealed by novel human amyloid precursor protein-specific antibodiesEndothelial nitric oxide deficiency promotes Alzheimer's disease pathologyTransgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions.Disruption of zinc homeostasis and the pathogenesis of senile dementia.Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer's disease.Reactive site-dependent phenotypic alterations in plasminogen activator inhibitor-1 transgenic mice.Exploring the differences between mouse mAβ(1-42) and human hAβ(1-42) for Alzheimer's disease related properties and neuronal cytotoxicity.Cross talk between neurometals and amyloidogenic proteins at the synapse and the pathogenesis of neurodegenerative diseases.The toxicity in vitro of beta-amyloid protein.Role of Species-Specific Primary Structure Differences in Aβ42 Assembly and NeurotoxicityRegulation of APP expression, biogenesis and metabolism by extracellular matrix and cytokines.Brain amyloid--a physicochemical perspective.Biochemistry and pathology of radical-mediated protein oxidation.Constitutive overactivation of protein kinase C in guinea pig brain increases alpha-secretory APP processing without decreasing beta-amyloid generation.Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture.Oxidative and hydrolytic properties of beta-amyloid.The transmembrane domain of the amyloid precursor protein in microsomal membranes is on both sides shorter than predicted.Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.Urea-based two-dimensional electrophoresis of beta-amyloid peptides in human plasma: evidence for novel Abeta species.The acute neurotoxic effect of beta-amyloid on mature cultures of rat hippocampal neurons is attenuated by the anti-oxidant U-78517F.Zinc, Carnosine, and Neurodegenerative Diseases.The neurotoxicity of amyloid beta protein in aged primates.Enhanced GFAP expression in astrocytes of transgenic mice expressing the human brain-specific trypsinogen IV.Effect of aluminium ions on liposomal membranes as detected by Laurdan fluorescence.A synthetic amino acid substitution of Tyr10 in Aβ peptide sequence yields a dominant negative variant in amyloidogenesis.
P2860
Q21284967-EEDD507D-69EA-4936-BA83-EC627F75EE4BQ24608911-4A44EB9B-F4F1-4A6E-A1F6-E23673510F1AQ28079843-7214E85B-9D27-458C-9BA8-85B7D45D5E3BQ28307760-EF6D35B0-C6CF-47B2-B63A-D5AC832288D8Q33368096-36C7BFC8-BD0F-47FC-AE91-F05EE09B366CQ33922664-0E7FEF49-D039-41A0-A674-46FA34E7CD36Q34053378-9F2FD342-D15F-4AF9-9561-0D9B3808B6E0Q34575537-EBAE2049-B3D5-42D8-BF77-5563A3FD0A06Q35952432-670BC04D-688A-4696-80AD-07D0D7ABB521Q36139139-094D6F27-68DC-46EF-81E8-428A2458350DQ36382397-EB1BE532-0C0E-4EED-8703-304FEFDC29AAQ36647438-22AE58C1-F7E9-4336-BDC5-F00440ED605EQ36983212-347A96FD-A586-4302-AF76-CBA57102FD67Q37017403-63AF0592-D0AA-4E5A-BDEF-D1D23AFB129FQ37157375-034AB131-D85E-4ECB-8D34-5689643B1C6FQ37235627-850AE59A-55B9-4FA5-9B12-9EFAA59EA1F5Q37302801-212CBA12-6868-4AF4-BBA6-30BF019BE708Q37979824-FAADFEE6-325F-4E1B-AC02-A37B3E594106Q38163821-A4F10514-7E4B-4B91-A0EB-EF789B2243ECQ38185153-F79344FB-B7F0-45E3-BF26-6A8187F99259Q38302669-56228744-31EC-4985-8C90-D84EBA5E5C6FQ39148362-D8DF542E-55C9-44F2-8100-B8B403BE4C65Q39314484-AEE1017A-9910-44F8-BB1D-4D5420E5FACEQ40422520-4AAFA939-8290-4249-915D-747BDD1992A9Q40483316-5ED71995-D8DD-4055-89A3-8331DD88B1A8Q40983159-62FE30E0-B6EA-4AC2-99AC-FAA145CC1FC8Q41061833-03BC6D7D-5F82-48B5-B844-621AA0E915F4Q41481967-87CA7C1E-EE3B-4D2C-8816-877AF45D9EF5Q41924331-E4AC6680-BFB7-4A16-8D49-AD1D39B3D7FAQ42805272-46A430FA-790F-47CF-9BE4-0B050DD9EDE0Q43650846-08FA5AD0-7724-4112-BF41-5E9275554BFBQ44231100-B91E63BE-3D02-4BAE-80EC-41B14BBD22FBQ44898890-584E378B-FF96-4790-BC51-05F0D2B29F89Q46959711-2036B050-6312-4447-A60A-8C1D5D82E85CQ47632702-B31F68B6-835F-4DEA-80EE-1EB9D911C057Q47831358-0823E8D0-BE86-4BE5-8CA3-187A5F1C02B6Q48488834-07BA0AF7-4AE0-4F9A-9CBD-75205C28167BQ48501206-000852C9-C955-4BC0-95BA-54AF09C639C7Q48604076-587F90E6-E258-4DDC-9F43-F1257F87A0B4Q48631163-F87912E6-B327-47B9-8FE4-DA1958CF9C04
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Amyloidogenicity of rodent and human beta A4 sequences.
@en
Amyloidogenicity of rodent and human beta A4 sequences.
@nl
type
label
Amyloidogenicity of rodent and human beta A4 sequences.
@en
Amyloidogenicity of rodent and human beta A4 sequences.
@nl
prefLabel
Amyloidogenicity of rodent and human beta A4 sequences.
@en
Amyloidogenicity of rodent and human beta A4 sequences.
@nl
P2093
P2860
P1433
P1476
Amyloidogenicity of rodent and human beta A4 sequences.
@en
P2093
P2860
P304
P356
10.1016/0014-5793(93)81399-K
P407
P577
1993-06-01T00:00:00Z